Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders

被引:21
|
作者
Eggert, Dawn [1 ]
Dash, Prasanta K. [1 ]
Serradji, Nawal [2 ]
Dong, Chang-Zhi [2 ]
Clayette, Pascal [3 ]
Heymans, Francoise [2 ]
Dou, Huanyu [1 ]
Gorantla, Santhi [1 ]
Gelbard, Harris A. [4 ,5 ,6 ,7 ]
Poluektova, Larisa [1 ]
Gendelman, Howard E. [1 ,8 ]
机构
[1] Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA
[2] Univ Paris 07, ITODYS Interfaces Truitements Org & Dynam Syst, CNRS, Equipe Pharmacochim Mol,UMR 7086, F-75013 Paris, France
[3] CEA, SPI Bio, Neurovirol Dept, F-92265 Fontenay Aux Roses, France
[4] Univ Rochester, Sch Med & Dent, Ctr Neural Dev & Dis, Rochester, NY 14642 USA
[5] Univ Rochester, Sch Med & Dent, Dept Neurol, Child Neurol Div, Rochester, NY 14642 USA
[6] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA
[7] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA
[8] Univ Nebraska, Med Ctr, Dept Internal Med, Omaha, NE 68198 USA
关键词
Platelet activating factor; PMS-601; Human immunodeficiency virus; Multinucleated giant cell; Nuclear factor kappa beta; Proline-rich tyrosine kinase 2; HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; CEREBELLAR GRANULE NEURONS; FOCAL ADHESION KINASE; TNF-ALPHA; SCID MICE; ARACHIDONIC-ACID; IL-10; PRODUCTION; PROTEIN-KINASE; HIV-1-INFECTED MACROPHAGES;
D O I
10.1016/j.jneuroim.2009.06.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The neutoregulatory activities of PMS-601, a platelet activating factor antagonist, were investigated in laboratory and animal models of HIV-1 encephalitis (HIVE). For the former. PMS-601 reduced monocyte-derived macrophage pro-inflammatory secretions, multinucleated giant cell (MGC) formation, and neuronal loss independent of antiretroviral responses. PMS-601 treatment of HIVE severe combined immunodeficient mice showed reduced microgliosis, MGCs and neurodegeneration. These observations support the further development of PMS-601 as an adjunctive therapy for HIV-1 associated neurocognitive disorders. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:47 / 59
页数:13
相关论文
共 50 条
  • [1] Platelet-activating factor receptor activation - An initiator step in HIV-1 neuropathogenesis
    Perry, SW
    Hamilton, JA
    Tjoelker, LW
    Dbaibo, G
    Dzenko, KA
    Epstein, LG
    Hannun, Y
    Whittaker, JS
    Dewhurst, S
    Gelbard, HA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (28) : 17660 - 17664
  • [2] Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment
    Schifitto, G
    Sacktor, N
    Marder, K
    McDermott, MP
    McArthur, JC
    Kieburtz, K
    Small, S
    Epstein, LG
    NEUROLOGY, 1999, 53 (02) : 391 - 396
  • [3] OCTYLONIUM BROMIDE, AN ANTAGONIST OF PLATELET-ACTIVATING FACTOR
    SUBISSI, A
    DELMONTE, M
    EVANGELISTA, S
    SANTICIOLI, P
    CRISCUOLI, M
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1989, 302 : 255 - 267
  • [4] The synthesis of platelet-activating factor modulates chemotaxis of monocytes induced by HIV-1 Tat
    Del Sorbo, L
    DeMartino, A
    Biancone, L
    Bussolati, B
    Conaldi, PG
    Toniolo, A
    Camussi, G
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1999, 29 (05) : 1513 - 1521
  • [5] Microglial HIV-1 Expression: Role in HIV-1 Associated Neurocognitive Disorders
    Li, Hailong
    McLaurin, Kristen A.
    Illenberger, Jessica M.
    Mactutus, Charles F.
    Booze, Rosemarie M.
    VIRUSES-BASEL, 2021, 13 (05):
  • [6] Platelet-activating factor and platelet-activating factor antagonists in acute pancreatitis
    Johnson, CD
    DIGESTIVE SURGERY, 1999, 16 (02) : 93 - 101
  • [7] A PLATELET-ACTIVATING FACTOR ANTAGONIST INHIBITS INTERLEUKIN-1-INDUCED INFLAMMATION
    RUBIN, RM
    ROSENBAUM, JT
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 154 (01) : 429 - 436
  • [8] Tat-induced platelet-activating factor synthesis contributes to the angiogenic effect of HIV-1 Tat
    Del Sorbo, L
    Arese, M
    Giraudo, E
    Tizzani, M
    Biancone, L
    Bussolino, F
    Camussi, G
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2001, 31 (02) : 376 - 383
  • [9] Platelet-activating factor
    Kingsnorth, AN
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 : 28 - 31
  • [10] PLATELET-ACTIVATING FACTOR
    FARR, RS
    WESTERN JOURNAL OF MEDICINE, 1984, 141 (04): : 506 - 506